Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120…
History, Art, Companies & Products
Explore the main themes, entities and connections around Biocon. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
biologics market limited company biosimilar syngene subsidiary international biosimilars indian biocon's us india research pharmaceutical viatris products drug sold also
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Biocon | Founded | 1978 (48 years ago) (1978) | 1.00 | infobox |
| Biocon | Founder | Kiran Mazumdar-Shaw | 1.00 | infobox |
| Biocon | Headquarters | Bengaluru, Karnataka, India | 1.00 | infobox |
| Biocon | Industry | Biopharmaceutical | 1.00 | infobox |
| Biocon | Industry | Biotechnology | 1.00 | infobox |
| Biocon | ISIN | INE376G01013 | 1.00 | infobox |
| Biocon | Key people | Kiran Mazumdar-Shaw (executive chairperson) | 1.00 | infobox |
| Biocon | Key people | Shreehas P Tambe (CEO & Managing Director, Biocon Limited) | 1.00 | infobox |
| Biocon | Net income | ₹1,013 crore (US$110 million) (2025) | 1.00 | infobox |
| Biocon | Number of employees | 16,545 (March 2023) | 1.00 | infobox |
| Biocon | Operating income | ₹4,374 crore (US$450 million) (2025) | 1.00 | infobox |
| Biocon | Products | Biologics | 1.00 | infobox |
| Biocon | Products | Small molecules | 1.00 | infobox |
| Biocon | Products | Branded formulations | 1.00 | infobox |
| Biocon | Products | Research services | 1.00 | infobox |
| Biocon | Revenue | ₹16,470 crore (US$1.7 billion) (2025) | 1.00 | infobox |
| Biocon | Subsidiaries | Biocon Biologics | 1.00 | infobox |
| Biocon | Subsidiaries | Syngene International | 1.00 | infobox |
| Biocon | Total assets | ₹58,797 crore (US$6.1 billion) (2025) | 1.00 | infobox |
| Biocon | Total equity | ₹27,712 crore (US$2.9 billion) (2025) | 1.00 | infobox |
| Biocon | Traded as | BSE: 532523 NSE: BIOCON | 1.00 | infobox |
| Biocon | Type | Public | 1.00 | infobox |
| Biocon | Website | www.biocon.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.